Affordability Assessment from a Static to Dynamic Concept: A Scenario-Based Assessment of Cardiovascular Medicines

International Journal of Environmental Research and Public Health
Leila ZareiZaheer-Ud-Din Babar

Abstract

The out-of-pocket payments for prescription medications can impose a financial burden on patients from low- and middle- incomes and who suffer from chronic diseases. The present study aims at evaluating the affordability of cardiovascular disease (CVD) medication in Iran. This includes measuring affordability through World Health Organization/Health Action International (WHO/HAI) methodology. In this method, affordability is characterized as the number of days' wages of the lowest-paid unskilled government worker. The different medication therapy scenarios are defined in mono-and combination therapy approaches. This method adds on to WHO/HAI methodology to discover new approaches to affordability assessments. The results show the differences in the medicines affordability when different approaches are used in mono-and combination therapy between 6 main sub-therapeutic groups of CVD. It indicates the medicine affordability is not a static concept and it changes dynamically between CVD therapeutic subgroups when it used alone or in combination with other medicines regarding patients' characteristics and medical conditions. Hypertension and anti-arrhythmia therapeutic groups had the most non-affordability and hyperlipidemia had th...Continue Reading

References

Mar 31, 2009·Lancet·L M Niëns, W B F Brouwer
Jun 11, 2010·BMC Cardiovascular Disorders·Maaike S M van MourikRichard O Laing
Jun 26, 2010·Diabetology & Metabolic Syndrome·Sanjay KalraNavneet Agrawal
Sep 8, 2011·Journal of Mid-life Health·Anita Patel
Mar 31, 2012·Bulletin of the World Health Organization·L M NiënsW B F Brouwer
May 26, 2012·Indian Journal of Community Medicine : Official Publication of Indian Association of Preventive & Social Medicine·Js ThakurNata Menabde
Oct 16, 2012·Australian Health Review : a Publication of the Australian Hospital Association·Alison PearceMarion Haas
Feb 16, 2013·Lancet·Ruth BonitaUNKNOWN Lancet NCD Action Group
Jul 6, 2013·Health Policy·L M Niëns, W B F Brouwer
Aug 13, 2013·PLoS Medicine·Thomas J Bollyky
Oct 3, 2013·European Journal of Internal Medicine·Boris BikbovGiuseppe Remuzzi
Dec 7, 2013·Expert Review of Pharmacoeconomics & Outcomes Research·John Fanourgiakis, Emmanuel Kanoupakis
Jan 1, 2014·African Journal of Primary Health Care & Family Medicine·Brenda S Mhlanga, Fatima Suleman
Mar 12, 2016·Bulletin of the World Health Organization·Stephen JanYong Huo
May 25, 2016·Circulation·Veronika J WirtzRichard O Laing
Aug 2, 2017·Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine·Joseph ChilcotKen Farrington
Nov 11, 2018·BMC Health Services Research·Xuemei ZhenHengjin Dong
May 29, 2019·Annual Review of Pharmacology and Toxicology·Michelle M Mello
Oct 16, 2019·Eastern Mediterranean Health Journal = La Revue De Santé De La Méditerranée Orientale = Al-Majallah Al-ṣiḥḥīyah Li-sharq Al-mutawassiṭ·Elham HeidariAkbar Abdollahiasl
Nov 16, 2019·The Malaysian Journal of Medical Sciences : MJMS·Huay Woon YouYusuf Al-Mubin Shaharin Anwar
Dec 12, 2019·Inquiry : a Journal of Medical Care Organization, Provision and Financing·Saval KhanalSamantha Hollingworth

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cardiovascular Disease Pathophysiology

Cardiovascular disease involves several different processes that contribute to the pathological mechanism, including hyperglycemia, inflammation, atherosclerosis, hypertension and more. Vasculature stability plays a critical role in the development of the disease. Discover the latest research on cardiovascular disease pathophysiology here.

Related Papers

The Lancet. Diabetes & Endocrinology
Robert A Hegele
© 2021 Meta ULC. All rights reserved